Next Quarterly Earnings
Thursday, July 30, 2026
CW 31
After-Hours
In 24 days
Gilead Sciences is a leading US biopharmaceutical company dedicated to discovering, developing, and marketing innovative medicines. The company focuses on creating treatments for life-threatening diseases such as HIV, viral hepatitis, and cancer, with the overarching goal of improving the lives of patients around the world through its groundbreaking research and therapies.